Select language:

Russia to start production of 2 anti-COVID-19 vaccines in September

 / Главная / Russkiy Mir Foundation / News / Russia to start production of 2 anti-COVID-19 vaccines in September

Russia to start production of 2 anti-COVID-19 vaccines in September


15.06.2020

Photo credit: mos.ru

Two vaccines against coronavirus are planned to be registered by the Russian authorities in early autumn, TASS reports.

According to Deputy Prime Minister Tatyana Golikova, the leaders in their development are the Gamalei Institute and the Vector center. It is planned to register the vaccines in August. 

The Gamalei Institute is working on a vaccine together with the 48th institute of the Russian defense department. They will conduct clinical trials in the summer. The developers suggest that the industrial production phase will begin in September.

Earlier, academician of the Russian Academy of Sciences Alexander Gunzburg, the head of the Gamalei Research Center for Epidemiology and Microbiology, expressed the hope that the vaccine would be ready for launch in mass production in late summer. Perhaps, the academician added, the first stage of vaccination would unfold in autumn. 

The Vector center of Virology and Biotechnology noted that the clinical trials of their vaccines were to be completed in early autumn. According to Rinat Maksyutov, who heads the center, trials should begin in June.

Russkiy Mir

News by subject

Publications

Italian entrepreneur Marco Maggi's book, "Russian to the Bone," is now accessible for purchase in Italy and is scheduled for release in Russia in the upcoming months. In the book, Marco recounts his personal odyssey, narrating each stage of his life as a foreigner in Russia—starting from the initial fascination to the process of cultural assimilation, venturing into business, fostering authentic friendships, and ultimately, reaching a deep sense of identifying as a Russian at his very core.